Reduced18F-Folate Conjugates as a New Class of PET Tracers for Folate Receptor Imaging
- 7 February 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 29 (4) , 1119-1130
Abstract
5-Methyltetrahydrofolate (5-MTHF), a reduced folate form, is the biologically active folate involved in many different metabolic processes. To date, there are no studies available in the literature on 18F-labeled 6S- and 6R-5-MTHF radiotracers for imaging FR-α-positive tissues. Therefore, the goal of this study was to synthesize four 18F-labeled 5-MTHF derivatives conjugated at either the α- or γ-carboxylic functionality of glutamate and to assess their suitability for folate receptor (FR)-targeting. Organic syntheses of the precursors and the four reference compounds, namely 6S-α, 6S-γ, 6R-α and 6R-γ-click-fluoroethyl-5-MTHF, were carried out in low to moderate overall chemical yields. The radiosyntheses of the α- and γ-conjugated 18F-labeled folate derivatives were accomplished in approximately 100 min, low radiochemical yields (1-7% d.c.) and high molar activities (139-245 GBq/µmol). Radiochemically pure tracers were obtained after the addition of a mixture of antioxidants consisting of sodium ascorbate and L-cysteine. In vitro, all four 5-MTHF conjugates showed similar binding affinities to FR-α (IC50 = 17.7-24.0 nM), whereas folic acid showed a significantly higher binding affinity to the FR-α. Cell uptake and internalization experiments with KB cells demonstrated specific uptake and internalization of the radiofolate conjugates. Metabolite studies in mice revealed high in vivo stability of the radiotracers in mice. Biodistribution and positron emission tomography (PET) imaging studies in FR-positive KB tumor-bearing mice demonstrated that the 6S- and 6R-5-MTHF conjugates exhibited a different accumulation pattern in various organs including the kidneys and the liver, whereas no significant differences in radioactivity accumulation in the kidneys and the liver were found for both the α- and γ-conjugated diastereoisomers. Despite the considerably lower binding affinities of the 5-MTHF derivatives compared to the corresponding folic acid conjugates similar high KB tumor uptake was observed for all the folate conjugates investigated (8-11% IA/g). Based on these results, we conclude that 18F-labeled 5-MTHF conjugates are a promising new class of radiotracers for targeting FR-positive tumor tissues.Keywords
Funding Information
- Merck KGaA
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (310030_156803, CRSII3_154490)
This publication has 27 references indexed in Scilit:
- Folic acid-conjugated superparamagnetic iron oxide nanoparticles for tumor-targeting MR imagingDrug Delivery, 2015
- Folate-Based Radiotracers for PET Imaging—Update and PerspectivesMolecules, 2013
- Radiosynthesis and Preclinical Evaluation of 3′-Aza-2′-[18F]fluorofolic Acid: A Novel PET Radiotracer for Folate Receptor TargetingBioconjugate Chemistry, 2013
- Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human resultsNature Medicine, 2011
- Fluorine-18 Click Radiosynthesis and Preclinical Evaluation of a New 18F-Labeled Folic Acid DerivativeBioconjugate Chemistry, 2008
- Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assayAnalytical Biochemistry, 2005
- Folate-targeted chemotherapyAdvanced Drug Delivery Reviews, 2004
- Folate-receptor-targeted radionuclide imaging agentsAdvanced Drug Delivery Reviews, 2004
- Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospectsJournal of Controlled Release, 2003
- Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implicationsCancer, 1994